FerGene is a new gene therapy company dedicated to creating and delivering innovative solutions to urologists and those affected by non-muscle invasive bladder cancer (NMIBC).

Biotechnology

FerGene

FerGene's headquarters in Cambridge, MA, United States

William Young

Evan Rachlin

Jean Frederic Paulsen

Jean Duvall

Paris Panayiotopoulos

Aaron Graff

The Directors and Vice Presidents team at FerGene oversees strategic planning, technical operations, and medical affairs, ensuring the successful development and delivery of gene therapies for non-muscle invasive bladder cancer (NMIBC). They provide executive leadership, manage cross-functional teams, and steer the company towards its mission of pioneering advanced treatments for urological conditions.

Directors and Vice Presidents

The Leadership Team at FerGene drives the strategic direction and operational excellence of the company, ensuring the successful development and delivery of innovative gene therapies for non-muscle invasive bladder cancer. Comprised of top executives across operations, technical affairs, and medical domains, the team fosters collaboration, cultivates talent, and aligns resources to advance the company's mission while addressing the needs of urologists and patients.

FerGene

Org chart

Teams

Directors and Vice Presidents

Leadership Team

Offices

FerGene

Org chart

Teams

Directors and Vice Presidents

Leadership Team

Offices

Related companies